Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Neutral
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Website
Althea Group Holdings Ltd.Telephone
N/A
Address
Suite 2, Level 50 360 Elizabeth Street Melbourne, Victoria (VIC) 3000
Description
Althea Group Holdings Ltd. is an investment company, which engages in the manufacture, sales, and distribution of cannabis-based medicines and recreational cannabis products. It operates through the following segments: Pharmaceutical Cannabis, Recreational Cannabis, and Corporate. The company was founded by Joshua Fegan on June 21, 2018 and is headquartered in Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.02 - 0.05
Trade Value (12mth)
AU$6,654.00
1 week
0%
1 month
-18.18%
YTD
-2.7%
1 year
-7.69%
All time high
1.45
EPS 3 yr Growth
41.00%
EBITDA Margin
-30.20%
Operating Cashflow
-$4m
Free Cash Flow Return
-24.30%
ROIC
-177.60%
Interest Coverage
-7.00
Quick Ratio
0.40
Shares on Issue (Fully Dilluted)
404m
HALO Sector
Healthcare
Next Company Report Date
28-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
04 December 24 |
Voluntary Suspension
×
Voluntary Suspension |
02 December 24 |
Pause in Trading
×
Pause in Trading |
02 December 24 |
Trading Halt
×
Trading Halt |
29 November 24 |
Results of Meeting
×
Results of Meeting |
21 November 24 |
Change in substantial holding
×
Change in substantial holding |
06 November 24 |
Peak Announces New Partnership with Simply Solventless
×
Peak Announces New Partnership with Simply Solventless |
04 November 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
01 November 24 |
Notice of Extraordinary General Meeting/Proxy Form
×
Notice of Extraordinary General Meeting/Proxy Form |
31 October 24 |
Q1FY25 Business Update Presentation
×
Q1FY25 Business Update Presentation |
31 October 24 |
Monthly Activities/Appendix 4C Cash Flow Report
×
Monthly Activities/Appendix 4C Cash Flow Report |
29 October 24 |
Completion of Sale of MyAccess Clinics
×
Completion of Sale of MyAccess Clinics |
17 October 24 |
Sale of MyAccess Clinics to Montu Group UK Ltd
×
Sale of MyAccess Clinics to Montu Group UK Ltd |
14 October 24 |
Response to ASX Price Query
×
Response to ASX Price Query |
02 October 24 |
Change in substantial holding
×
Change in substantial holding |
12 September 24 |
Update on Peak USA Production and Operations
×
Update on Peak USA Production and Operations |
09 September 24 |
Change in substantial holding
×
Change in substantial holding |
06 September 24 |
Final Director's Interest Notice
×
Final Director's Interest Notice |
02 September 24 |
Initial Notice of Director's Interest
×
Initial Notice of Director's Interest |
30 August 24 |
Annual Report to shareholders
×
Annual Report to shareholders |
30 August 24 |
AGH FY24 Annual Report Commentary
×
AGH FY24 Annual Report Commentary |
30 August 24 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
22 August 24 |
Change in substantial holding
×
Change in substantial holding |
19 August 24 |
Resignation of Chairman and Appointment of New Chairman
×
Resignation of Chairman and Appointment of New Chairman |
13 August 24 |
Change in substantial holding
×
Change in substantial holding |
31 July 24 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.